Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 9371602, 12 pages
https://doi.org/10.1155/2017/9371602
Research Article

Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs

The MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China

Correspondence should be addressed to Ruomei Qi; moc.361@iqiemour

Received 9 February 2017; Revised 22 May 2017; Accepted 30 May 2017; Published 12 July 2017

Academic Editor: Ryuichi Morishita

Copyright © 2017 Kun Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Prajapati, P. K. Jena, P. Rajput, K. Purandhar, and S. Seshadri, “Understanding and modulating the toll like receptors (TLRs) and NOD like receptors (NLRs) cross talk in type 2 diabetes,” Current Diabetes Reviews, vol. 10, no. 3, pp. 190–200, 2014. View at Publisher · View at Google Scholar
  2. S. Rosa Ramirez and M. Ravi Krishna Dasu, “Toll-like receptors and diabetes complications: recent advances,” Current Diabetes Reviews, vol. 8, no. 6, pp. 480–488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Jialal, B. A. Huet, H. Kaur, A. Chien, and S. Devaraj, “Increased toll-like receptor activity in patients with metabolic syndrome,” Diabetes Care, vol. 35, no. 4, pp. 900–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Q. Wang, Y. S. Jeelall, L. L. Ferguson, and K. Horikawa, “Toll-like receptors and cancer: MYD88 mutation and inflammation,” Frontiers in Immunology, vol. 5, no. 367, article 00367, p. 10, 2014. View at Google Scholar
  5. J. E. Cole, C. Kassiteridi, and C. Monaco, “Toll-like receptors in atherosclerosis: a ‘Pandora’s box’ of advances and controversies,” Trends in Pharmacological Sciences, vol. 34, no. 11, pp. 629–636, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. R. Aroor, S. McKarns, V. G. Demarco, G. Jia, and J. R. Sowers, “Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance,” Metabolism, vol. 62, no. 11, pp. 1543–1552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Spirig, J. Tsui, and S. Shaw, “The emerging role of TLR and innate immunity in cardiovascular disease,” Cardiology Research and Practice, vol. 2012, Article ID 181394, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Chmielewski, A. Olejnik, K. Sikorski et al., “STAT1-dependent signal integration between IFNγ and TLR4 in vascular cells reflect pro-atherogenic responses in human atherosclerosis,” PloS One, vol. 9, no. 12, article e113318, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Jagannathan, H. Hasturk, Y. Liang et al., “TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients,” Journal of Immunology, vol. 183, no. 11, pp. 7461–7470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Jialal, H. Kaur, and S. Devaraj, “Toll-like receptor status in obesity and metabolic syndrome: a translational perspective,” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 1, pp. 39–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. N. R. Rojo-Botello, A. L. García-Hernández, and L. Moreno-Fierros, “Expression of toll-like receptors 2, 4 and 9 is increased in gingival tissue from patients with type 2 diabetes and chronic periodontitis,” Journal of Periodontal Research, vol. 47, no. 1, pp. 62–73, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Yokoyama, T. Hosoi, and K. Ozawa, “Stearoyl-CoA desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice,” Gene, vol. 497, no. 2, pp. 340–343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Li, L. Song, X. Gao, W. Chang, and X. Qin, “Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes,” Experimental & Molecular Medicine, vol. 44, no. 4, pp. 260–267, 2012. View at Publisher · View at Google Scholar
  14. D. De Keyzer, S. A. Karabina, W. Wei et al., “Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 12, pp. 2041–2046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. H. Kim, S. J. Lee, K. W. Seo et al., “PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway,” Journal of Lipid Research, vol. 54, no. 10, pp. 2678–2686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Agrawal, M. K. Jaiswal, V. Ilievski, K. D. Beaman, T. Jilling, and E. Hirsch, “Platelet activating factor (PAF): a role in preterm delivery and an essential interaction with toll-like receptor (TLR) signaling in mice,” Biology of Reproduction, vol. 91, no. 5, p. 119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. S. Bitencourt, V. L. Bessi, D. N. Huynh et al., “Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury,” Journal of Cellular and Molecular Medicine, vol. 17, no. 12, pp. 1554–1565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Liu, G. Zhao, Y. Yan, L. Bao, B. Chen, and R. Qi, “Ginkgolide B reduces atherogenesis and vascular inflammation in ApoE−/− mice,” PloS One, vol. 7, no. 5, article e36237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. S. Waitkus, U. M. Chandrasekharan, B. Willard et al., “Signal integration and gene induction by a functionally distinct STAT3 phosphoform,” Molecular and Cellular Biology, vol. 34, no. 10, pp. 1800–1811, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Zhong, Z. Wen, and J. E. Darnell, “Stat 3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6,” Science, vol. 264, no. 5155, pp. 95–98, 1994. View at Publisher · View at Google Scholar
  21. D. Guschin, N. Rogers, and J. Briscoe, “A major role for the protein tyrosine JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6,” The EMBO Journal, vol. 14, no. 7, pp. 1421–1429, 1995. View at Google Scholar
  22. A. Lin, G. Wang, H. Zhao et al., “TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells,” Oncoimmunology, vol. 5, no. 2, article e1074376, 2016. View at Google Scholar
  23. H. J. Cho and K. S. Nam, “Inhibitory effect of ginkgolide B on platelet aggregation in a cAMP- and cGMP-dependent manner by activated MMP-9,” Journal of Biochemistry and Molecular Biology, vol. 40, no. 5, pp. 678–683, 2007. View at Google Scholar
  24. L. Ma, X. Liu, Y. Zhao, B. Chen, X. Li, and R. Qi, “Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells,” PloS One, vol. 2013, no. 8, article e74769, 2013. View at Google Scholar
  25. X. Liu, Y. Yan, L. Bao, B. Chen, Y. Zhao, and R. Qi, “Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets,” Thrombosis Research, vol. 134, no. 5, pp. 1066–1073, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Aponte, W. Jiang, M. Lakkis et al., “Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer,” Cancer Research, vol. 68, no. 14, pp. 5839–5848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. G. Chuffa, B. A. Fioruci-Fontanelli, L. O. Mendes et al., “Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer,” BMC Cancer, vol. 15, p. 34, 2015. View at Google Scholar
  28. Q. Zhang, C. Wang, Z. Liu et al., “Notch signal suppresses toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor κB activation,” The Journal of Biological Chemistry, vol. 287, no. 9, pp. 6208–6217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Küper, F. X. Beck, and W. Neuhofer, “Toll-like receptor 4 activates NF-κB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells,” American Journal of Physiology - Renal Physiology, vol. 302, no. 1, pp. F38–F46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Larbi, T. Fülöp, and G. Pawelec, “Immune receptor signaling, aging and autoimmunity,” Advances in Experimental Medicine and Biology, vol. 640, pp. 312–324, 2008. View at Google Scholar
  31. U. Rajamani and I. Jialal, “Hyperglycemia induces toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy,” Journal of Diabetes Research, vol. 2014, Article ID 790902, 15 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Lin, W. H. Yiu, H. J. Wu et al., “Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 23, no. 1, pp. 86–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Ahmad, A. Al-Mass, V. Atizado et al., “Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation,” Journal of Inflammation, vol. 9, no. 1, p. 48, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Knapp, S. von Aulock, M. Leendertse et al., “Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor,” Journal of Immunology, vol. 180, no. 5, pp. 3478–3484, 2008. View at Publisher · View at Google Scholar
  35. H. A. Jo, J. Y. Kim, S. H. Yang et al., “The role of local IL6/JAK2/STAT3 signaling in high glucose-induced podocyte hypertrophy,” Kidney Research and Clinical Practice, vol. 35, no. 4, pp. 212–218, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Watanabe, S. Sekine, I. Naguro, Y. Sekine, and H. Ichijo, “Apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway-dependent cytoplasmic translocation of the orphan nuclear receptor NR4A2 is required for oxidative stress-induced necrosis,” The Journal of Biological Chemistry, vol. 290, no. 17, pp. 10791–10803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Li, J. Hu, T. He et al., “P38/MAPK contributes to endothelial barrier dysfunction via MAP4 phosphorylation-dependent microtubule disassembly in inflammation-induced acute lung injury,” Scientific Reports, vol. 5, article 8895, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. F. Liu, D. Zheng, G. C. Fan, T. Peng, and L. Su, “Heat stress prevents lipopolysaccharide-induced apoptosis in pulmonary microvascular endothelial cells by blocking calpain/p38 MAPK signaling,” Apoptosis, vol. 21, no. 8, pp. 896–904, 2016. View at Publisher · View at Google Scholar · View at Scopus